سعر كلافوران Claforan‏ 250مجم فيال 2026

Cefotaxime 250 mg vial for IM/IV injection (Sanofi), a third-generation cephalosporin antibiotic.

• Most frequent (>1%): local injection-site reactions (4.3%), hypersensitivity (rash, pruritus, fever, eosinophilia; 2.4%) and gastrointestinal effects (colitis, diarrhoea, nausea, vomiting; 1.4%).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to cefotaxime sodium or the cephalosporin group of antibiotics.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Inquire about previous hypersensitivity to cephalosporins, penicillins or other drugs; give with caution in type I penicillin hypersensitivity; discontinue if an allergic reaction occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• ProbenecidProbenecid reduced cefotaxime clearance by about 50% and increased steady-state plasma levels by about 80%.DailyMed (U.S. National Library of Medicine)

• No evidence of embryotoxicity or teratogenicity in animal studies; cefotaxime crosses the placenta; no well-controlled studies in pregnant women; use in pregnancy only if clearly needed.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Cefotaxime (as sodium): Bactericidal; inhibits bacterial cell-wall synthesis via penicillin-binding proteins; parenteral third-generation cephalosporin.